Hypoxia‐Targeted siRNA Delivery
- 19 February 2014
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 53 (13) , 3362-3366
Abstract
Altered vasculature and the resultant chaotic tumor blood flow lead to the appearance in fast‐growing tumors of regions with gradients of oxygen tension and acute hypoxia (less than 1.4 % oxygen).1 Due to its roles in tumorigenesis and resistance to therapy, hypoxia represents a problem in cancer therapy.1, 2 Insufficient delivery of therapeutic agents to the hypoxic regions in solid tumors is recognized as one of the causes of resistance to therapy.1, 3 This led to the development of hypoxia imaging agents,4 and the use of hypoxia‐activated anticancer prodrugs.2a Here we show the first example of the hypoxia‐induced siRNA uptake and silencing using a nanocarrier consisting of polyethyleneglycol 2000, azobenzene, polyethyleneimine (PEI)(1.8 kDa), and 1,2‐dioleyl‐sn‐glycero‐3‐phosphoethanolamine (DOPE) units (the nanocarrier is referred to as PAPD), where azobenzene imparts hypoxia sensitivity and specificity.4a We report hypoxia‐activated green fluorescent protein (GFP) silencing in vitro and its downregulation in GFP‐expressing tumors after intravenous administration. The proposed nanoformulation represents a novel tumor‐environment‐responsive modality for cancer targeting and siRNA delivery.Keywords
This publication has 31 references indexed in Scilit:
- Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatmentJournal of Molecular Medicine, 2013
- Highly Discriminating Photorelease of Anticancer Drugs Based on Hypoxia Activatable Phototrigger Conjugated Chitosan NanoparticlesAdvanced Materials, 2013
- Hypoxia-activated prodrugs forge ahead in cancerNature Biotechnology, 2012
- In Vivo Delivery of RNAi with Lipid-Based NanoparticlesAnnual Review of Biomedical Engineering, 2011
- Targeting hypoxia in cancer therapyNature Reviews Cancer, 2011
- Layer-by-Layer Nanoparticles with a pH-Sheddable Layer forin VivoTargeting of Tumor HypoxiaACS Nano, 2011
- Hypoxia-Sensitive Fluorescent Probes for in Vivo Real-Time Fluorescence Imaging of Acute IschemiaJournal of the American Chemical Society, 2010
- Significance of nitroimidazole compounds and hypoxia‐inducible factor‐1 for imaging tumor hypoxiaCancer Science, 2009
- Molecular Imaging of HypoxiaJournal of Nuclear Medicine, 2008
- Exploiting tumour hypoxia in cancer treatmentNature Reviews Cancer, 2004